Latest Minimed Paradigm Stories
Largest Capacity Insulin Pump Available in U.S. - For People with Greater Insulin Needs SAN DIEGO, May 19, 2015 /PRNewswire/-- Tandem Diabetes Care®, Inc.
LAUSANNE, Switzerland and WILSONVILLE, Oregon, May 11, 2015 /PRNewswire/ -- Debiotech of Switzerland and iSense CGM, Inc.
A group of teenagers are taking a vacation from diabetes in order to test-drive an artificial pancreas in real-world conditions.
The world's first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret.
SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc.
9 major insurance companies in Canada approved the reimbursement of the Montméd Timesulin under "standard group policies that include coverage for diabetic supplies". MONTREAL,
Company's Network and Technology Enable Trial of Artificial Pancreas in California NEW YORK, Aug.
Insulin pumps are significantly more effective at controlling blood glucose (sugar) in people with type 2 diabetes who have failed to respond to the usual standard of care, multiple daily insulin injections.
DUBLIN, May 22, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wqkgq3/continuous)
- A hairdresser.